Citations (110)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Hsin-Ju Chen, Wei-Hsin Huang, Hsin-Lung Chan & Lee-Ching Hwang. (2021) Improvement in Cardiometabolic Risk Factors During Smoking Cessation Treatment in Patients with Type 2 Diabetes: A Retrospective Cohort Study. Diabetes, Metabolic Syndrome and Obesity 14, pages 1695-1702.
Read now
Read now
Xin Zhou, Mei Luo, Sha Zhou, Zhiling Cheng, Zhongpei Chen & Xiaoxia Yu. (2021) Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients. Diabetes, Metabolic Syndrome and Obesity 14, pages 379-385.
Read now
Read now
J. J. A. De Smidt, H. J. Odendaal, D. G. Nel, H. Nolan, C. Du Plessis, L. T. Brink & A. Oelofse. (2021) In utero teratogen exposure and cardiometabolic risk in 5-year-old children: a prospective pediatric study. The Journal of Maternal-Fetal & Neonatal Medicine 34:22, pages 3740-3749.
Read now
Read now
Nobuya Inagaki, Shin-ichi Harashima & Hiroaki Iijima. (2018) Canagliflozin for the treatment of type 2 diabetes: a comparison between Japanese and non-Japanese patients. Expert Opinion on Pharmacotherapy 19:8, pages 895-908.
Read now
Read now
Carlos I. Alatorre, Byron J. Hoogwerf, Mark A. Deeg, David R. Nelson, Theresa M. Hunter, Wee Teck Ng & Mark D. Rekhter. (2018) Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control. Current Medical Research and Opinion 34:2, pages 337-343.
Read now
Read now
Dario Rahelić, Eugen Javor, Tomo Lucijanić & Marko Skelin. (2017) Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus: a new perspective on sodium–glucose co-transporter 2 inhibitors. Annals of Medicine 49:1, pages 51-62.
Read now
Read now
James W Reed. (2016) Impact of sodium–glucose cotransporter 2 inhibitors on blood pressure. Vascular Health and Risk Management 12, pages 393-405.
Read now
Read now
Bindu Chamarthi, Michael Ezrokhi, Dean Rutty & Anthony H. Cincotta. (2016) Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin. Postgraduate Medicine 128:8, pages 761-769.
Read now
Read now
Xueying Tan & Jingbo Hu. (2016) Combination therapy for type 2 diabetes: dapagliflozin plus metformin. Expert Opinion on Pharmacotherapy 17:1, pages 117-126.
Read now
Read now
Carlos Morillas, Rosa Feliciano, Pablo Fernández Catalina, Carla Ponte, Marta Botella, João Rodrigues, Enric Esmatjes, Javier Lafita, Luis Lizán, Ignacio Llorente, Cristóbal Morales, Jorge Navarro-Pérez, Domingo Orozco-Beltran, Silvia Paz, Antonio Ramirez de Arellano, Cristina Cardoso & Maribel Tribaldos Causadias. (2015) Patients’ and physicians’ preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment. Patient Preference and Adherence 9, pages 1443-1458.
Read now
Read now
Heshmat Sepehri Moghaddam, Saeed Samarghandian & Tahereh Farkhondeh. (2015) Effect of bisphenol A on blood glucose, lipid profile and oxidative stress indices in adult male mice. Toxicology Mechanisms and Methods 25:7, pages 507-513.
Read now
Read now
Yunsuk Koh, Heidi Bidstrup & David L Nichols. (2014) Niacin increased glucose, insulin, and C-peptide levels in sedentary nondiabetic postmenopausal women. International Journal of Women's Health 6, pages 913-920.
Read now
Read now
Rosemarie Lajara. (2014) The potential role of sodium glucose co-transporter 2 inhibitors in combination therapy for type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 15:17, pages 2565-2585.
Read now
Read now
Articles from other publishers (97)
Fadime GÖK. (2022) Tip 2 diyabetli bireylerin kardiyovasküler hastalık risk faktörleri bilgisi ve ilişkili faktörlerler. Pamukkale Medical Journal, pages 21-21.
Crossref
Crossref
Emine Karaman, Aslı Kalkım & Banu Pınar Şarer Yürekli. (2021) Determining the Cardiovascular Disease Risk Factor Knowledge and Related Factors Among Adults With Type 2 Diabetes Mellitus. Clinical Nursing Research 31:4, pages 579-587.
Crossref
Crossref
Nasr E. Nasr & Kadry M. Sadek. (2022) Role and mechanism(s) of incretin-dependent therapies for treating diabetes mellitus. Environmental Science and Pollution Research 29:13, pages 18408-18422.
Crossref
Crossref
Sunanda Rajkumari, Somorjit Singh Ningombam, Varhlun Chhungi, Masan Kambo Newmei, Naorem Kiranmala Devi, Prakash Ranjan Mondal & Kallur Nava Saraswathy. (2021) Association of ACE I/D gene polymorphism and related risk factors in impaired fasting glucose and type 2 diabetes: a study among two tribal populations of North-East India. Molecular Biology Reports 49:2, pages 1037-1044.
Crossref
Crossref
Francisco Arrieta, Juan Pedro-Botet, Pedro Iglesias, Juan Carlos Obaya, Laura Montanez, Gonzalo Fernando Maldonado, Antonio Becerra, Jorge Navarro, J.C. Perez, Romina Petrecca, José Luis Pardo, Josep Ribalta, Víctor Sánchez-Margalet, Santiago Duran, Francisco Javier Tébar & Manuel Aguilar. (2022) Diabetes mellitus y riesgo cardiovascular: actualización de las recomendaciones del Grupo de Trabajo de Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2021). Clínica e Investigación en Arteriosclerosis 34:1, pages 36-55.
Crossref
Crossref
Francisco Arrieta, Juan Pedro-Botet, Pedro Iglesias, Juan Carlos Obaya, Laura Montanez, Gonzalo Fernando Maldonado, Antonio Becerra, Jorge Navarro, J.C. Perez, Romina Petrecca, José Luis Pardo, Josep Ribalta, Víctor Sánchez-Margalet, Santiago Duran, Francisco Javier Tébar & Manuel Aguilar. (2022) Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021). Clínica e Investigación en Arteriosclerosis (English Edition) 34:1, pages 36-55.
Crossref
Crossref
Dandan Huang, Guangbi Li, Owais M. Bhat, Yao Zou, Ningjun Li, Joseph K. Ritter & Pin-Lan Li. (2022) Exosome Biogenesis and Lysosome Function Determine Podocyte Exosome Release and Glomerular Inflammatory Response during Hyperhomocysteinemia. The American Journal of Pathology 192:1, pages 43-55.
Crossref
Crossref
Cassandra C. Derella, Martha S. Tingen, Anson Blanks, Samantha J. Sojourner, Matthew A. Tucker, Jeffrey Thomas & Ryan A. Harris. (2021) Smoking cessation reduces systemic inflammation and circulating endothelin-1. Scientific Reports 11:1.
Crossref
Crossref
Søren S. Lund, Naveed Sattar, Afshin Salsali, Dietmar Neubacher & Henry N. Ginsberg. (2021) Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials. Diabetes, Obesity and Metabolism 23:12, pages 2763-2774.
Crossref
Crossref
Ayça TÜRER CABBAR, Mustafa Aytek ŞIMŞEK, Burak HÜNÜK, Olcay ÖZVEREN, Özge GÜZELBURÇ & Muzaffer DEĞERTEKIN. (2021) EVALUATION OF THE RELATIONSHIP BETWEEN MPV AND SEVERITY OF CORONARY ARTERY DISEASE IN TYPE 2 DIABETIC PATIENTS WITHOUT ACUTE CORONARY SYNDROMEAKUT KORONER SENDROM OLMAYAN TİP 2 DİYABETİK HASTALARDA KORONER ARTER HASTALIĞI YAYGINLIĞI İLE MPV İLİŞKİSİNİN ARAŞTIRILMASI. SDÜ Tıp Fakültesi Dergisi 28:3, pages 411-417.
Crossref
Crossref
Cecilia B Rosales, Catalina A Denman, Melanie L Bell, Elsa Cornejo, Maia Ingram, María del Carmen Castro Vásquez, Jesús Eduardo Gonzalez-Fagoaga, Benjamín AcevesII,II,, Tomas Nuño, Elizabeth J Anderson & Jill Guernsey de Zapien. (2021)
Meta Salud Diabetes
for cardiovascular disease prevention in Mexico: a cluster-randomized behavioural clinical trial
. International Journal of Epidemiology 50:4, pages 1272-1282.
Crossref
Crossref
Yong-Jae Lee, Byoungjin Park, Kyung-Won Hong & Dong-Hyuk Jung. (2021) Gallbladder Polyps Increase the Risk of Ischaemic Heart Disease Among Korean Adults. Frontiers in Medicine 8.
Crossref
Crossref
Dandan Huang, Guangbi Li, Qinghua Zhang, Owais M. Bhat, Yao Zou, Joseph K. Ritter & Pin-Lan Li. (2021) Contribution of podocyte inflammatory exosome release to glomerular inflammation and sclerosis during hyperhomocysteinemia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1867:7, pages 166146.
Crossref
Crossref
Huajie Zou, Ping Yin, Liegang Liu, Wu Duan, Pu Li, Yan Yang, Wenjun Li, Qunchuan Zong & Xuefeng Yu. (2020) Association between weight cycling and risk of developing diabetes in adults: A systematic review and meta‐analysis. Journal of Diabetes Investigation 12:4, pages 625-632.
Crossref
Crossref
Thaíse Gabriele da Silva Brito, Ana Paula Sant’Anna da Silva, Rebeca Xavier da Cunha, Caíque Silveira Martins da Fonseca, Tiago Ferreira da Silva Araújo, Janaína Karin de Lima Campos, Weber Melo Nascimento, Hallysson Douglas Andrade de Araújo, Joanda Paolla Raimundo e Silva, Josean Fechine Tavares, Bianka Santana dos Santos & Vera Lúcia de Menezes Lima. (2021) Anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic activities of Plinia cauliflora (Mart.) Kausel (Brazilian grape) epicarp. Journal of Ethnopharmacology 268, pages 113611.
Crossref
Crossref
Stan Vluggen, Math Candel, Ciska Hoving, Nicolaas C Schaper & Hein de Vries. (2021) A Web-Based Computer-Tailored Program to Improve Treatment Adherence in Patients With Type 2 Diabetes: Randomized Controlled Trial. Journal of Medical Internet Research 23:2, pages e18524.
Crossref
Crossref
Katarzyna Nabrdalik, Katarzyna Krzyżak, Weronika Hajzler, Karolina Drożdż, Hanna Kwiendacz, Janusz Gumprecht & Gregory Y. H. Lip. (2021) Fat, Sugar or Gut Microbiota in Reducing Cardiometabolic Risk: Does Diet Type Really Matter?. Nutrients 13:2, pages 639.
Crossref
Crossref
Malak Almutairi, Keshav Gopal, Amanda A. Greenwell, Adrian Young, Robert Gill, Hanin Aburasayn, Rami Al Batran, Jadin J. Chahade, Manoj Gandhi, Farah Eaton, Ryan J. Mailloux & John R. Ussher. (2021) The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy. Canadian Journal of Cardiology 37:1, pages 140-150.
Crossref
Crossref
Nosayba Al-Azzam, Sayer Al-Azzam, Lina Elsalem & Reema Karasneh. (2021) Hypertension prevalence and associated factors among patients with diabetes: A retrospective cross-sectional study from Jordan. Annals of Medicine and Surgery 61, pages 126-131.
Crossref
Crossref
Shmuel Somer & Andrew P. Levy. (2020) The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes. International Journal of Molecular Sciences 22:1, pages 287.
Crossref
Crossref
Huajie Zou, Yongping Xu, Xi Chen, Ping Yin, Danpei Li, Wenjun Li, Junhui Xie, Shiying Shao, Liegang Liu & Xuefeng Yu. (2020) Predictive values of ANGPTL8 on risk of all-cause mortality in diabetic patients: results from the REACTION Study. Cardiovascular Diabetology 19:1.
Crossref
Crossref
Hai-Ting Zhou, De-Li Zhao, Guo-Kun Wang, Tian-Zuo Wang, Hong-Wei Liang & Jin-Ling Zhang. (2020) Assessment of high sensitivity C-reactive protein and coronary plaque characteristics by computed tomography in patients with and without diabetes mellitus. BMC Cardiovascular Disorders 20:1.
Crossref
Crossref
Shalini Srivastava, Robert Girandola & Ankul Suresh Kokate. (2020) Effect of Oxyjun™ on Adipose Tissue Inflammation - A Randomized, Placebo-Controlled Clinical Study. International Journal of Physical Education, Fitness and Sports, pages 37-50.
Crossref
Crossref
Yu ChenDeborah RolkaHui XieSharon Saydah. (2020) Imputed State-Level Prevalence of Achieving Goals To Prevent Complications of Diabetes in Adults with Self-Reported Diabetes — United States, 2017–2018. MMWR. Morbidity and Mortality Weekly Report 69:45, pages 1665-1670.
Crossref
Crossref
Chiara D’Angelo, Sara Franceschelli, José Luis Quiles & Lorenza Speranza. (2020) Wide Biological Role of Hydroxytyrosol: Possible Therapeutic and Preventive Properties in Cardiovascular Diseases. Cells 9:9, pages 1932.
Crossref
Crossref
Mykola Khalangot, Dmytro Krasnienkov & Alexander Vaiserman. (2020) Telomere length in different metabolic categories: Clinical associations and modification potential. Experimental Biology and Medicine 245:13, pages 1115-1121.
Crossref
Crossref
Cosmin Mihai Vesa, Loredana Popa, Amorin Remus Popa, Marius Rus, Andreea Atena Zaha, Simona Bungau, Delia Mirela Tit, Raluca Anca Corb Aron & Dana Carmen Zaha. (2020) Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors. Diagnostics 10:5, pages 314.
Crossref
Crossref
Navneet Kumar Dubey, Abhinay Kumar Singh, Rajni Dubey & Win-Ping Deng. 2020. Biopolymer-Based Formulations. Biopolymer-Based Formulations
353
363
.
Daniel Modin, Rasmus Møgelvang, Peter Godsk Jørgensen, Magnus Thorsten Jensen, Jelena P. Seferovic & Tor Biering-Sørensen. (2019) Left ventricular concentric geometry predicts incident diabetes mellitus independent of established risk factors in the general population: the Copenhagen City Heart Study. Cardiovascular Diabetology 18:1.
Crossref
Crossref
Osei Sarfo-Kantanka, Fred Stephen Sarfo, Ishmael Kyei, Charles Agyemang & Jean Claude Mbanya. (2019) Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010–2015- a retrospective cohort study. BMC Endocrine Disorders 19:1.
Crossref
Crossref
Àngels Molló, Anna Berenguera, Esther Rubinat, Bogdan Vlacho, Manel Mata, Josep Franch, Bonaventura Bolíbar & Dídac Mauricio. (2019) INTEGRA study protocol: primary care intervention in type 2 diabetes patients with poor glycaemic control. BMC Family Practice 20:1.
Crossref
Crossref
Solomon Nuhoho, Jatin Gupta, Brian Bekker Hansen, Mary Fletcher-Louis, Tam Dang-Tan & Abby Paine. (2019) Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis. Diabetes Therapy 10:6, pages 2183-2199.
Crossref
Crossref
Dalia El-Lebedy. (2019) Association of serum angiopoietin-like protein 2 with elevated risk of cardiovascular diseases in subjects with type 2 diabetes. Journal of Diabetes and its Complications 33:11, pages 107421.
Crossref
Crossref
Nagaeva Gulnora. 2019. Cardiac Diseases and Interventions in 21st Century. Cardiac Diseases and Interventions in 21st Century.
Xue Han, Jeff McCombs, Michelle Chu, J. Samantha Dougherty & D. Steven Fox. (2019) Impact of early initiation of antihypertensive medications for patients with hypertension or elevated blood pressure. Journal of Hypertension 37:6, pages 1276-1284.
Crossref
Crossref
Peigang Tian, Xiangyang Zheng, Mingzhi Li, Weiwei Li & Qingliang Niu. (2019) Long‑term prognostic value of coronary computed tomography angiography for asymptomatic patients with CAD in type 2 diabetes mellitus. Experimental and Therapeutic Medicine.
Crossref
Crossref
Soghra Rabizadeh, Mohammad Ali Mansournia, Salome Sadat Salehi, Pegah Khaloo, Hamid Alemi, Hassan Mirbolouk, Micheal Joseph Blaha, Alireza Esteghamati & Manouchehr Nakhjavani. (2019) Comparison of primary versus secondary prevention of cardiovascular disease in patients with type2 diabetes: Focus on achievement of ABC goals. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:3, pages 1733-1737.
Crossref
Crossref
Golbon Sohrab, Hanieh Roshan, Samira Ebrahimof, Omid Nikpayam, Giti Sotoudeh & Fereidoun Siasi. (2019) Effects of pomegranate juice consumption on blood pressure and lipid profile in patients with type 2 diabetes: A single-blind randomized clinical trial. Clinical Nutrition ESPEN 29, pages 30-35.
Crossref
Crossref
Nagaraj Malipatil, Helene A. Fachim, Kirk Siddals, Bethany Geary, Gwen Wark, Nick Porter, Simon Anderson, Rachelle Donn, Michelle Harvie, Anthony D. Whetton, Martin J. Gibson & Adrian Heald. (2019) Data Independent Acquisition Mass Spectrometry Can Identify Circulating Proteins That Predict Future Weight Loss with a Diet and Exercise Programme. Journal of Clinical Medicine 8:2, pages 141.
Crossref
Crossref
Manuel Sánchez, Miguel Romero, Manuel Gómez-Guzmán, Juan Tamargo, Francisco Pérez-Vizcaino & Juan Duarte. (2019) Cardiovascular Effects of Flavonoids. Current Medicinal Chemistry 26:39, pages 6991-7034.
Crossref
Crossref
Yilin Yoshida & Eduardo J. Simoes. 2019. Type 2 Diabetes [Working Title]. Type 2 Diabetes [Working Title].
Giovanna Castoldi, Cira R. T. di Gioia, Francesca Roma, Raffaella Carletti, Giuseppina Manzoni, Andrea Stella, Gianpaolo Zerbini & Gianluca Perseghin. (2018) Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats. Acta Diabetologica 56:1, pages 97-104.
Crossref
Crossref
Dustin M. Lee, Micah L. Battson, Dillon K. Jarrell, Shuofei Hou, Kayl E. Ecton, Tiffany L. Weir & Christopher L. Gentile. (2018) SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice. Cardiovascular Diabetology 17:1.
Crossref
Crossref
Md Rizman Md Lazin Md Lazim, Amilia Aminuddin, Kalaivani Chellappan, Azizah Ugusman, Norizam Salamt, Oteh Maskon, Wan Amir Nizam Wan Ahmad, Mohd Shawal Faizal Mohamad & Ahmad Khairuddin Mohamed Yusof. (2018) Development and Validation of Heart Rate -incorporated Finger Photoplethysmography Fitness Index Algorithm for Cardiovascular Disease Risk Assessment. Development and Validation of Heart Rate -incorporated Finger Photoplethysmography Fitness Index Algorithm for Cardiovascular Disease Risk Assessment.
S. Vluggen, C. Hoving, N.C. Schaper & H. de Vries. (2018) A web-based program to improve treatment adherence in patients with type 2 diabetes: Development and study protocol. Contemporary Clinical Trials 74, pages 38-45.
Crossref
Crossref
Dan Tang, Liu Liu, Dildar Ajiakber, Jianping Ye, Jianjun Xu, Xuelei Xin & Haji Akber Aisa. (2018) Anti-diabetic Effect of Punica granatum Flower Polyphenols Extract in Type 2 Diabetic Rats: Activation of Akt/GSK-3β and Inhibition of IRE1α-XBP1 Pathways. Frontiers in Endocrinology 9.
Crossref
Crossref
Dalia H. El-Lebedy, Alshaymaa A. Ibrahim & Ingy O. Ashmawy. (2018) Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:5, pages 643-648.
Crossref
Crossref
Panhu Zhu, Weijun Huang, Jiaming Li, Xiaodong Ma, Mengqi Hu, Yujun Wang, Qinlong Xu & Xianna Wang. (2018) Design, synthesis chalcone derivatives as AdipoR agonist for type 2 diabetes. Chemical Biology & Drug Design 92:2, pages 1525-1536.
Crossref
Crossref
Sangyong Choi, Xian Liu & Zui Pan. (2018) Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases. Acta Pharmacologica Sinica 39:7, pages 1120-1132.
Crossref
Crossref
James E. Frampton. (2018) Empagliflozin: A Review in Type 2 Diabetes. Drugs 78:10, pages 1037-1048.
Crossref
Crossref
Michal Witkowski, Lars Wilkinson, Neil Webb, Alan Weids, Divina Glah & Hrvoje Vrazic. (2018) A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Anti-Diabetic Drugs. Diabetes Therapy 9:3, pages 1149-1167.
Crossref
Crossref
Johan Jendle, Xin Fang, Yang Cao, Leif Bojö, Bo K. Nilsson, Fredric Hedberg, Irene Santos-Pardo & Thomas Nyström. (2018) Effects on repetitive 24-hour ambulatory blood pressure in subjects with type II diabetes randomized to liraglutide or glimepiride treatment both in combination with metformin: a randomized open parallel-group study. Journal of the American Society of Hypertension 12:5, pages 346-355.
Crossref
Crossref
Rahimeh Rahimi, Jamshid Karimi, Iraj Khodadadi, Heidar Tayebinia, Nejat Kheiripour, Mohammad Hashemnia & Fatemeh Goli. (2018) Silymarin ameliorates expression of urotensin II (U-II) and its receptor (UTR) and attenuates toxic oxidative stress in the heart of rats with type 2 diabetes. Biomedicine & Pharmacotherapy 101, pages 244-250.
Crossref
Crossref
Francisco Arrieta, Pedro Iglesias, Juan Pedro-Botet, Antonio Becerra, Emilio Ortega, Juan Carlos Obaya, Andreu Nubiola, Gonzalo Fernando Maldonado, Maria del Mar Campos, Romina Petrecca, José Luis Pardo, Víctor Sánchez-Margalet, José Juan Alemán, Jorge Navarro, Santiago Duran, Francisco Javier Tébar, Manuel Aguilar & Fernando Escobar. (2018) Diabetes mellitus y riesgo cardiovascular. Actualización de las recomendaciones del Grupo de Trabajo de Diabetes y Riesgo Cardiovascular de la Sociedad Española de Diabetes (SED, 2018). Clínica e Investigación en Arteriosclerosis 30:3, pages 137-153.
Crossref
Crossref
Francisco Arrieta, Pedro Iglesias, Juan Pedro-Botet, Antonio Becerra, Emilio Ortega, Juan Carlos Obaya, Andreu Nubiola, Gonzalo Fernando Maldonado, Maria del Mar Campos, Romina Petrecca, José Luis Pardo, Víctor Sánchez-Margalet, José Juan Alemán, Jorge Navarro, Santiago Duran, Francisco Javier Tébar, Manuel Aguilar & Fernando Escobar. (2018) Diabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018). Clínica e Investigación en Arteriosclerosis (English Edition) 30:3, pages 137-153.
Crossref
Crossref
Nobuya Inagaki, Shin-ichi Harashima, Kohei Kaku, Kazuoki Kondo, Nobuko Maruyama, Makiko Otsuka, Yutaka Kawaguchi & Hiroaki Iijima. (2018) Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 20:4, pages 812-820.
Crossref
Crossref
Samantha Sabo, Catalina Denman Champion, Melanie L Bell, Elsa Cornejo Vucovich, Maia Ingram, Celina Valenica, Maria del Carmen Castro Vasquez, Eduardo Gonzalez-Fagoaga, Jill Geurnsey de Zapien & Cecilia B Rosales. (2018) Meta Salud Diabetes study protocol: a cluster-randomised trial to reduce cardiovascular risk among a diabetic population of Mexico. BMJ Open 8:3, pages e020762.
Crossref
Crossref
Mingxia Bi, Qian Jiao, Xixun Du & Hong Jiang. (2018) Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson’s Disease Models. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Wachirawadee Malakul, Sirinat Pengnet, Chanon Kumchoom & Sakara Tunsophon. (2018) Naringin ameliorates endothelial dysfunction in fructose-fed rats. Experimental and Therapeutic Medicine.
Crossref
Crossref
NursyafizaB Mohammad, Nor AzlinaA Rahman & Mainul Haque. (2018) Knowledge, attitude, and practice regarding the risk of cardiovascular diseases in patients attending outpatient clinic in Kuantan, Malaysia. Journal of Pharmacy And Bioallied Sciences 10:1, pages 7.
Crossref
Crossref
Alfredo García-Layana, Marta S. Figueroa, Luis Arias, Alfredo Adán, Francisco Cabrera, Maximino Abraldes, Álvaro Fernández-Vega, Rafael Navarro, Enrique Cervera, Rufino Silva, Felix Armadá, Juan Donate & José Maria Ruiz-Moreno. (2018) Clinical Decision-Making when Treating Diabetic Macular Edema Patients with Dexamethasone Intravitreal Implants. Ophthalmologica 240:2, pages 61-72.
Crossref
Crossref
S. Vluggen, C. Hoving, N.C. Schaper & H. de Vries. (2018) Exploring beliefs on diabetes treatment adherence among Dutch type 2 diabetes patients and healthcare providers. Patient Education and Counseling 101:1, pages 92-98.
Crossref
Crossref
Farideh Razi, Katayoon Forouzanfar, Fatemeh Bandarian & Ensieh Nasli-Esfahani. (2017) LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations. Journal of Diabetes & Metabolic Disorders 16:1.
Crossref
Crossref
Jaime Davidson, Sanjay Kalra, Vikram Singh, Mayuresh Fegade, Gursimran Singh & Amey Mane. (2017) Resolving the KgA1c paradox in the management of type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 11, pages S159-S168.
Crossref
Crossref
Y. H. Lee-Barkey, B. Stratmann & D. Tschöpe. (2017) Inkretinbasierte DiabetesmedikamenteIncretin-based diabetes drugs. Der Diabetologe 13:7, pages 498-504.
Crossref
Crossref
Surbhi Shah, John Galdo, Elizabeth D. Cox, Megan A. Moreno & Henry N. Young. (2017) Impact of Bubble Packaging on Adherence to Long-Term Oral Medications Used to Prevent Cardiovascular Disease. Journal of Pharmacy Technology 33:3, pages 114-120.
Crossref
Crossref
Mu'ath Ibrahim Tanash, Donna Fitzsimons, Vivien Coates & Christi Deaton. (2017) An evaluation of the effectiveness of self‐management interventions for people with type 2 diabetes after an acute coronary syndrome: a systematic review. Journal of Clinical Nursing 26:11-12, pages 1458-1472.
Crossref
Crossref
J Visser, P J van Staden, P Soma, A V Buys & E Pretorius. (2017) The stabilizing effect of an oligomeric proanthocyanidin on red blood cell membrane structure of poorly controlled Type II diabetes. Nutrition & Diabetes 7:5, pages e275-e275.
Crossref
Crossref
Lu Han, Wen-Jun Shen, Stefanie Bittner, Fredric B Kraemer & Salman Azhar. (2017) PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α. Future Cardiology 13:3, pages 259-278.
Crossref
Crossref
Mitchel Tate, David J. GrieveRebecca H. Ritchie. (2017) Are targeted therapies for diabetic cardiomyopathy on the horizon?. Clinical Science 131:10, pages 897-915.
Crossref
Crossref
Annette Boles, Ramesh Kandimalla & P. Hemachandra Reddy. (2017) Dynamics of diabetes and obesity: Epidemiological perspective. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:5, pages 1026-1036.
Crossref
Crossref
Gemma SangüesaSonali ShaligramFarjana AktherNúria Roglans, Juan C. Laguna, Roshanak RahimianMarta Alegret. (2017) Type of supplemented simple sugar, not merely calorie intake, determines adverse effects on metabolism and aortic function in female rats. American Journal of Physiology-Heart and Circulatory Physiology 312:2, pages H289-H304.
Crossref
Crossref
Hiroyuki Tanaka, Kazuhiko Takano, Hiroaki Iijima, Hajime Kubo, Nobuko Maruyama, Toshio Hashimoto, Kenji Arakawa, Masanori Togo, Nobuya Inagaki & Kohei Kaku. (2016) Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus. Advances in Therapy 34:2, pages 436-451.
Crossref
Crossref
Micah L. Battson, Dustin M. Lee, Dillon K. Jarrell, Shoufei Hou, Kayl E. Ecton, Anna B. Phan & Christopher L. Gentile. (2017) Tauroursodeoxycholic Acid Reduces Arterial Stiffness and Improves Endothelial Dysfunction in Type 2 Diabetic Mice. Journal of Vascular Research 54:5, pages 280-287.
Crossref
Crossref
Carlos Gabriel de Lade, João Carlos Bouzas Marins, Luciana Moreira Lima, Cristiane Junqueira de Carvalho, Robson Bonoto Teixeira, Maicon Rodrigues Albuquerque, Janice Sepúlveda Reis & Paulo Roberto dos Santos Amorim. (2016) Effects of different exercise programs and minimal detectable changes in hemoglobin A1c in patients with type 2 diabetes. Diabetology & Metabolic Syndrome 8:1.
Crossref
Crossref
Hye Eun Yoon, Eun Young Mo, Seok Joon Shin, Sung Dae Moon, Je Ho Han & Eun Sook Kim. (2016) Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes. Cardiovascular Diabetology 15:1.
Crossref
Crossref
Dalia El-Lebedy, Hala M. Raslan & Asmaa M. Mohammed. (2016) Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease. Cardiovascular Diabetology 15:1.
Crossref
Crossref
Giuseppe ManciaChristopher P. CannonIlkka TikkanenCordula ZellerLudwin LeyHans J. WoerleUli C. BroedlOdd Erik Johansen. (2016) Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication. Hypertension 68:6, pages 1355-1364.
Crossref
Crossref
Randula Haththotuwa. (2016) Cardiovascular complications of diabetes. InnovAiT: Education and inspiration for general practice 9:11, pages 694-701.
Crossref
Crossref
Dalia El-Lebedy, Enas Rasheed, Mona Kafoury, Dalia Abd-El Haleem, Eman Awadallah & Ingy Ashmawy. (2016) Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus. Journal of Diabetes and its Complications 30:4, pages 580-585.
Crossref
Crossref
Francisco Arrieta, Pedro Iglesias, Juan Pedro-Botet, Francisco Javier Tébar, Emilio Ortega, Andreu Nubiola, Jose Luis Pardo, Gonzálo Fernando Maldonado, Juan Carlos Obaya, Pablo Matute, Romina Petrecca, Nuria Alonso, Elena Sarabia, Victor Sánchez-Margalet, José Juan Alemán, Jorge Navarro, Antonio Becerra, Santiago Duran, Manuel Aguilar & Fernando Escobar-Jiménez. (2016) Diabetes mellitus y riesgo cardiovascular: recomendaciones del Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2015). Atención Primaria 48:5, pages 325-336.
Crossref
Crossref
Sergey V. Kakorin, Ruben A. Iskandaryan & Ashot M. Mkrtumyan. (2016) Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials. Diabetes mellitus 19:2, pages 141-149.
Crossref
Crossref
William B. White, René H. Cuadra, Eric Lloyd, George L. Bakris & Stuart Kupfer. (2016) Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes. Journal of Hypertension 34:4, pages 788-797.
Crossref
Crossref
Chiara Seghieri, Laura Policardo, Paolo Francesconi & Giuseppe Seghieri. (2016) Gender differences in the relationship between diabetes process of care indicators and cardiovascular outcomes. The European Journal of Public Health 26:2, pages 219-224.
Crossref
Crossref
Yan-Ming Tian, Yan Liu, Sheng Wang, Yi Dong, Tong Su, Hui-Jie Ma & Yi Zhang. (2016) Anti-diabetes effect of chronic intermittent hypobaric hypoxia through improving liver insulin resistance in diabetic rats. Life Sciences 150, pages 1-7.
Crossref
Crossref
Xin Li, You-Ping Deng, Miao Yang, Yu-Wen Wu, Su-Xin Sun & Jia-Zhong Sun. (2016) Triglyceride to high-density lipoprotein cholesterol ratio and carotid intima-medial thickness in Chinese adolescents with newly diagnosed type 2 diabetes mellitus. Pediatric Diabetes 17:2, pages 87-92.
Crossref
Crossref
M. Nauck. (2016) Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors. Diabetes, Obesity and Metabolism 18:3, pages 203-216.
Crossref
Crossref
Sten Madsbad. (2016) Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?. Journal of Diabetes and its Complications 30:2, pages 374-385.
Crossref
Crossref
Geir Reinvik Ulimoen, Anne Pernille Ofstad, Knut Endresen, Lars Gullestad, Odd Erik Johansen & Arne Borthne. (2015) Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes - A cross-sectional study. BMC Cardiovascular Disorders 15:1.
Crossref
Crossref
Jessika M Lobraico, Lauren C DiLello, Amber D Butler, Marie Elena Cordisco, Joann R Petrini & Ramin Ahmadi. (2015) Effects of krill oil on endothelial function and other cardiovascular risk factors in participants with type 2 diabetes, a randomized controlled trial. BMJ Open Diabetes Research & Care 3:1, pages e000107.
Crossref
Crossref
Tejas P. Singh, Venkat N. Vangaveti & Usman H. Malabu. (2015) Dipeptidyl peptidase-4 inhibitors and their potential role in the management of atherosclerosis—A review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 9:4, pages 223-229.
Crossref
Crossref
Xiaomu Kong, Qi Zhao, Xiaoyan Xing, Bo Zhang, Xuelian Zhang, Jing Hong & Wenying Yang. (2015) Genetic Variants Associated with Lipid Profiles in Chinese Patients with Type 2 Diabetes. PLOS ONE 10:8, pages e0135145.
Crossref
Crossref
Корниенко, E. Kornienko, Ойноткинова & O. Oynotkinova. (2015) Modern views on the etiopathogenesis of myocardial infarction in diabetes mellitus type 2 and methods of treatment (literature review). Journal of New Medical Technologies. eJournal 9:2, pages 0-0.
Crossref
Crossref
Francisco Arrieta, Pedro Iglesias, Juan Pedro-Botet, Francisco Javier Tébar, Emilio Ortega, Andreu Nubiola, Jose Luis Pardo, Gonzálo Fernando Maldonado, Juan Carlos Obaya, Pablo Matute, Romina Petrecca, Nuria Alonso, Elena Sarabia, Victor Sánchez-Margalet, José Juan Alemán, Jorge Navarro, Antonio Becerra, Santiago Duran, Manuel Aguilar & Fernando Escobar-Jiménez. (2015) Diabetes mellitus y riesgo cardiovascular: recomendaciones del Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2015). Clínica e Investigación en Arteriosclerosis 27:4, pages 181-192.
Crossref
Crossref
Mireia Urpi-Sarda, Enrique Almanza-Aguilera, Sara Tulipani, Francisco J. Tinahones, Jordi Salas-Salvadó & Cristina Andres-Lacueva. (2015) Metabolomics for Biomarkers of Type 2 Diabetes Mellitus: Advances and Nutritional Intervention Trends. Current Cardiovascular Risk Reports 9:3.
Crossref
Crossref
Etheresia Pretorius, Janette Bester, Natasha Vermeulen, Sajee Alummoottil, Prashilla Soma, Antoinette V Buys & Douglas B Kell. (2015) Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics. Cardiovascular Diabetology 14:1, pages 30.
Crossref
Crossref
Alice Marmugi, Frederic Lasserre, Diane Beuzelin, Simon Ducheix, Laurence Huc, Arnaud Polizzi, Maud Chetivaux, Thierry Pineau, Pascal Martin, Hervé Guillou & Laila Mselli-Lakhal. (2014) Adverse effects of long-term exposure to bisphenol A during adulthood leading to hyperglycaemia and hypercholesterolemia in mice. Toxicology 325, pages 133-143.
Crossref
Crossref